Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

被引:470
|
作者
Miller, Joseph D. [1 ,2 ]
van der Most, Robbert G. [1 ,2 ]
Akondy, Rama S. [1 ,2 ]
Glidewell, John T. [1 ,2 ]
Albott, Sophia [1 ,2 ]
Masopust, David [1 ,2 ]
Murali-Krishna, Kaja [1 ,2 ]
Mahar, Patryce L. [1 ,2 ]
Edupuganti, Srilatha [1 ,2 ]
Lalor, Susan [1 ,2 ]
Germon, Stephanie [1 ,2 ]
Del Rio, Carlos [1 ,2 ]
Mulligan, Mark J. [1 ,2 ]
Staprans, Silvija I. [1 ,2 ]
Altman, John D. [1 ,2 ]
Feinberg, Mark B. [1 ,2 ]
Ahmed, Rafi [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Hope Clin, Atlanta, GA 30322 USA
关键词
D O I
10.1016/j.immuni.2008.02.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To explore the human T cell response to acute viral infection, we performed a longitudinal analysis of CD8(+) T cells responding to the live yellow fever virus and smallpox vaccines-two highly successful human vaccines. Our results show that both vaccines generated a brisk primary effector CD8(+) T cell response of substantial magnitude that could be readily quantitated with a simple set of four phenotypic markers. Secondly, the vaccine-induced T cell response was highly specific with minimal bystander effects. Thirdly, virus-specific CD8(+) T cells passed through an obligate effector phase, contracted more than 90% and gradually differentiated into long-lived memory cells. Finally, these memory cells were highly functional and underwent a memory differentiation program distinct from that described for human CD8(+) T cells specific for persistent viruses. These results provide a benchmark for CD8(+) T cell responses induced by two of the most effective vaccines ever developed.
引用
收藏
页码:710 / 722
页数:13
相关论文
共 50 条
  • [1] Insights into human CD8+ T-cell memory using the yellow fever and smallpox vaccines
    Ahmed, Rafi
    Akondy, Rama S.
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (03): : 340 - 345
  • [2] Peroxiredoxin II Regulates Effector and Secondary Memory CD8+ T Cell Responses
    Michalek, Ryan D.
    Crump, Katie E.
    Weant, Ashley E.
    Hiltbold, Elizabeth M.
    Juneau, Daniel G.
    Moon, Eun-Yi
    Yu, Dae-Yeul
    Poole, Leslie B.
    Grayson, Jason M.
    JOURNAL OF VIROLOGY, 2012, 86 (24) : 13629 - 13641
  • [3] The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
    Akondy, Rama S.
    Monson, Nathan D.
    Miller, Joseph D.
    Edupuganti, Srilatha
    Teuwen, Dirk
    Wu, Hong
    Quyyumi, Farah
    Garg, Seema
    Altman, John D.
    Del Rio, Carlos
    Keyserling, Harry L.
    Ploss, Alexander
    Rice, Charles M.
    Orenstein, Walter A.
    Mulligan, Mark J.
    Ahmed, Rafi
    JOURNAL OF IMMUNOLOGY, 2009, 183 (12): : 7919 - 7930
  • [4] Origin of CD8+ effector and memory T cell subsets
    Stemberger, Christian
    Neuenhahn, Michael
    Buchholz, Veit R.
    Busch, Dirk H.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2007, 4 (06) : 399 - 405
  • [5] Memory CD8+ T cell responses to cancer
    Han, Jichang
    Khatwani, Nikhil
    Searles, Tyler G.
    Turk, Mary Jo
    Angeles, Christina, V
    SEMINARS IN IMMUNOLOGY, 2020, 49
  • [6] Transcriptional regulation of effector and memory CD8+ T cell fates
    Thaventhiran, James E. D.
    Fearon, Douglas T.
    Gattinoni, Luca
    CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (03) : 321 - 328
  • [7] Spatial determinates of effector and memory CD8+ T cell fates
    Duckworth, Brigette C.
    Qin, Raymond Z.
    Groom, Joanna R.
    IMMUNOLOGICAL REVIEWS, 2022, 306 (01) : 76 - 92
  • [8] Transcriptional control of effector and memory CD8+ T cell differentiation
    Susan M. Kaech
    Weiguo Cui
    Nature Reviews Immunology, 2012, 12 : 749 - 761
  • [9] Transcriptional control of effector and memory CD8+ T cell differentiation
    Kaech, Susan M.
    Cui, Weiguo
    NATURE REVIEWS IMMUNOLOGY, 2012, 12 (11) : 749 - 761
  • [10] Deletion of PTPN22 improves effector and memory CD8+ T cell responses to tumors
    Brownlie, Rebecca J.
    Wright, David
    Zamoyska, Rose
    Salmond, Robert J.
    JCI INSIGHT, 2019, 4 (16)